Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 108Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Leukemia 15Lymphoma 14Burkitt Lymphoma 14Recurrence 10Lymphoma, Non-Hodgkin 10Lymphoma, Mantle-Cell 10Waldenstrom Macroglobulinemia 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Immunoglobulin Light-chain Amyloidosis 8Neoplasms, Plasma Cell 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, B-Cell, Marginal Zone 6Smoldering Multiple Myeloma 5Neoplasms 5Lymphoma, Follicular 5Leukemia, Biphenotypic, Acute 5Hodgkin Disease 5Neoplasm Metastasis 4Nausea 4Breast Neoplasms 4Vomiting 3Renal Insufficiency 3Lymphoma, Large-Cell, Anaplastic 3Leukemia, Plasma Cell 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hematologic Neoplasms 3Brain Neoplasms 3Blast Crisis 3

Interventions

Ocoxin 2niraparib 1anlotinib 1Thalidomide 1Sunitinib 1Spironolactone 1Paclitaxel 1Melphalan 1Leuprolide 1Filgrastim 1Etoposide 1Doxorubicin 1Dexamethasone 1Cyclophosphamide 1Cisplatin 1Carboplatin 1Calcium Dobesilate 1CP protocol 1Bortezomib 1Bevacizumab 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Endocrine System Diseases × Calcium Dobesilate × Clear all
NCT01548573 2017-06-14

Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment

University of Iowa

Phase 2 Terminated
19 enrolled 7 charts
Plasma cell

Amyloidosis, Endocrine System Diseases, Multiple Myeloma, Paraproteinemias, Polyneuropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡